MedTrace Logo

Physical Activity on Postural Stability and Coordination in Children With Posterior Fossa Tumor

NCT04528316 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-08-04

No results posted yet for this study

Summary

Medulloblastoma is a rapidly-growing tumor of the cerebellum, this area controls balance, posture and sophisticated motor functions like finer hand movements, speech, and swallowing. It has been reported that those children fall frequently so the purpose of this study is to investigate the effectiveness of balance and coordination training in these Children.

Conditions

  • Posterior Fossa Tumor
  • Medulloblastoma, Childhood

Interventions

BEHAVIORAL

Pilates Core Stability Exercises program

Twenty patients will receive Pilates core stability exercises program ONLY. Total Period: 12 Weeks Stages: Three stages: * Stage I: Warm-up: consists of four Pilates motions: 1. Breathing: 2. Rolling back: 3. Coccyx-curl: 4. Hundred breathing: * Stage II: Work-out: consists of twelve Pilates motions: 1. Single leg stretch: 2. Straight leg raise: 3. Basic bridge: 4. Bridging variation: 5. Quadruped: 6. Clap with seal motion 7. Mermaid twist: 8. Swimming: 9. Double leg stretch: 10. Shoulder bridge: 11. Swan dive: 12. Leg full front: * Stage III: Cool-down: consists of three Pilates motions: 1. Rest position: 2. Cat with arm/leg extension: 3. Breathing:

BEHAVIORAL

Balance Program

Total Period: 12 Weeks. The designed HUMAC program will work on the modified clinical test of sensory integration of balance (mCTSIB) with eyes open and with eyes closed, the center of pressure (COP) and the limit of stability test (LOS).

BEHAVIORAL

Coordination

Total Period: 12 Weeks. Coordination will be assessed using BOT2, Bilateral coordination (Sub test No.4) composed of 7 items and Upper-Limb coordination (Sub test No.7) composed of 7 items too. The raw scores are recorded first then it is converted into point scores, then subtest total point score is obtained by adding point scores.

Sponsors & Collaborators

  • Children's Cancer Hospital Egypt 57357

    lead OTHER

Principal Investigators

  • Mahmoud Usama Mahmoud Ahmed, MSc · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-06
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04528316 on ClinicalTrials.gov